Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
| Org | Common People |
|---|---|
| Jack Miller Center | Dick Uihlein |
| Uline, Inc. | Dick Uihlein |
| Ed Uihlein Family Foundation | Dick Uihlein |
| General Bindings Corporation | Dick Uihlein |
| Types | Organization, Business |
| Start date | 2000 |